Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

In 2005, we performed the largest survey on clinical trials of biotherapies for all solid tumors and found indirect evidence of a publication bias: editors of medical journals were more prone to publish positive results independently from the quality of the studies. We collected data from 2003 to 20...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Ottaiano, Alessandro, Cassata, Antonino, Capozzi, Monica, De Divitiis, Chiara, De Stefano, Alfonso, Avallone, Antonio
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861183/
https://ncbi.nlm.nih.gov/pubmed/29594042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00062
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi